Le GKT831 de Genkyotex prévient de multiples complications de l’hypertension portale dans un modèle préclinique

NEXT STORY
Basilea erweitert Phase-2-Studie mit Derazantinib beim intrahepatischen Gallengangskarzinom (iCCA) um Studienkohorte für Patienten mit Mutation oder Amplifikation des FGFR2-Gens
PREV STORY
ESPERITE N.V. (ESP) publishes its half-year report. Revenues, results and consolidated equity were impacted by adverse market conditions on the stem cell business.
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Coherus and Junshi Biosciences Announce Toripalimab in Combination with Chemotherapy Met Primary Progression Free Survival (PFS) Endpoint as First Line Treatment for Recurrent or Metastatic Nasopharyngeal Carcinoma (NPC)

author_avatar
NASDAQ Market News

Roche’s ENSPRYNG®️ (satralizumab) approved in Japan for adults and children with neuromyelitis optica spectrum disorder

author_avatar
NASDAQ Market News

GigaGen to Present Poster at the 2021 American Association for Cancer Research (AACR) Virtual Annual Meeting

author_avatar
NASDAQ Market News